[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Nonalcoholic Steatohepatitis (NASH) Market Professional Survey Report 2018

March 2018 | 115 pages | ID: GCEC642D8A3EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Nonalcoholic Steatohepatitis (NASH) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Boehringer Ingelheim
  • Cerenis Therapeutics
  • Connexios Life Sciences
  • Genfit
  • Islet Sciences
  • Nimbus Therapeutics
  • Verva Pharmaceuticals
  • Viking Therapeutics
  • Astazeneca Plc
  • Galmed Pharmaceuticals
  • GENFIT SA
  • Gilead Science
  • Novo Nordisk
  • Immuron
  • Intercepts Pharmaceuticals
  • Enzo Biochem
  • Tobira Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Weight Loss Treatment
  • Insulin-Sensitizing Agents
  • Lipid-Lowering Drugs
  • Antioxidants
  • Other
By Application, the market can be split into
  • Hospitals
  • Clinics
  • Research Institute
  • Other
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Nonalcoholic Steatohepatitis (NASH) Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF NONALCOHOLIC STEATOHEPATITIS (NASH)

1.1 Definition and Specifications of Nonalcoholic Steatohepatitis (NASH)
  1.1.1 Definition of Nonalcoholic Steatohepatitis (NASH)
  1.1.2 Specifications of Nonalcoholic Steatohepatitis (NASH)
1.2 Classification of Nonalcoholic Steatohepatitis (NASH)
  1.2.1 Weight Loss Treatment
  1.2.2 Insulin-Sensitizing Agents
  1.2.3 Lipid-Lowering Drugs
  1.2.4 Antioxidants
  1.2.5 Other
1.3 Applications of Nonalcoholic Steatohepatitis (NASH)
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Research Institute
  1.3.4 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NONALCOHOLIC STEATOHEPATITIS (NASH)

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nonalcoholic Steatohepatitis (NASH)
2.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
2.4 Industry Chain Structure of Nonalcoholic Steatohepatitis (NASH)

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NONALCOHOLIC STEATOHEPATITIS (NASH)

3.1 Capacity and Commercial Production Date of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017

4 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Nonalcoholic Steatohepatitis (NASH) Capacity and Growth Rate Analysis
  4.2.2 2017 Nonalcoholic Steatohepatitis (NASH) Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate Analysis
  4.3.2 2017 Nonalcoholic Steatohepatitis (NASH) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Nonalcoholic Steatohepatitis (NASH) Sales Price
  4.4.2 2017 Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis (Company Segment)

5 NONALCOHOLIC STEATOHEPATITIS (NASH) REGIONAL MARKET ANALYSIS

5.1 North America Nonalcoholic Steatohepatitis (NASH) Market Analysis
  5.1.1 North America Nonalcoholic Steatohepatitis (NASH) Market Overview
  5.1.2 North America 2013-2018E Nonalcoholic Steatohepatitis (NASH) Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis
  5.1.4 North America 2017 Nonalcoholic Steatohepatitis (NASH) Market Share Analysis
5.2 China Nonalcoholic Steatohepatitis (NASH) Market Analysis
  5.2.1 China Nonalcoholic Steatohepatitis (NASH) Market Overview
  5.2.2 China 2013-2018E Nonalcoholic Steatohepatitis (NASH) Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis
  5.2.4 China 2017 Nonalcoholic Steatohepatitis (NASH) Market Share Analysis
5.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Analysis
  5.3.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Overview
  5.3.2 Europe 2013-2018E Nonalcoholic Steatohepatitis (NASH) Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis
  5.3.4 Europe 2017 Nonalcoholic Steatohepatitis (NASH) Market Share Analysis
5.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Analysis
  5.4.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Overview
  5.4.2 Southeast Asia 2013-2018E Nonalcoholic Steatohepatitis (NASH) Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis
  5.4.4 Southeast Asia 2017 Nonalcoholic Steatohepatitis (NASH) Market Share Analysis
5.5 Japan Nonalcoholic Steatohepatitis (NASH) Market Analysis
  5.5.1 Japan Nonalcoholic Steatohepatitis (NASH) Market Overview
  5.5.2 Japan 2013-2018E Nonalcoholic Steatohepatitis (NASH) Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis
  5.5.4 Japan 2017 Nonalcoholic Steatohepatitis (NASH) Market Share Analysis
5.6 India Nonalcoholic Steatohepatitis (NASH) Market Analysis
  5.6.1 India Nonalcoholic Steatohepatitis (NASH) Market Overview
  5.6.2 India 2013-2018E Nonalcoholic Steatohepatitis (NASH) Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price Analysis
  5.6.4 India 2017 Nonalcoholic Steatohepatitis (NASH) Market Share Analysis

6 GLOBAL 2013-2018E NONALCOHOLIC STEATOHEPATITIS (NASH) SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales by Type
6.2 Different Types of Nonalcoholic Steatohepatitis (NASH) Product Interview Price Analysis
6.3 Different Types of Nonalcoholic Steatohepatitis (NASH) Product Driving Factors Analysis
  6.3.1 Weight Loss Treatment of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  6.3.2 Insulin-Sensitizing Agents of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  6.3.3 Lipid-Lowering Drugs of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  6.3.4 Antioxidants of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  6.3.5 Other of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis

7 GLOBAL 2013-2018E NONALCOHOLIC STEATOHEPATITIS (NASH) SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Nonalcoholic Steatohepatitis (NASH) Consumption by Application
7.2 Different Application of Nonalcoholic Steatohepatitis (NASH) Product Interview Price Analysis
7.3 Different Application of Nonalcoholic Steatohepatitis (NASH) Product Driving Factors Analysis
  7.3.1 Hospitals of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  7.3.2 Clinics of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  7.3.3 Research Institute of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis
  7.3.4 Other of Nonalcoholic Steatohepatitis (NASH) Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NONALCOHOLIC STEATOHEPATITIS (NASH)

8.1 Boehringer Ingelheim
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Boehringer Ingelheim 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Boehringer Ingelheim 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.2 Cerenis Therapeutics
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Cerenis Therapeutics 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Cerenis Therapeutics 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.3 Connexios Life Sciences
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Connexios Life Sciences 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Connexios Life Sciences 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.4 Genfit
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Genfit 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Genfit 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.5 Islet Sciences
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Islet Sciences 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Islet Sciences 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.6 Nimbus Therapeutics
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Nimbus Therapeutics 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Nimbus Therapeutics 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.7 Verva Pharmaceuticals
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Verva Pharmaceuticals 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Verva Pharmaceuticals 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.8 Viking Therapeutics
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Viking Therapeutics 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Viking Therapeutics 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.9 Astazeneca Plc
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Astazeneca Plc 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Astazeneca Plc 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.10 Galmed Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Galmed Pharmaceuticals 2017 Nonalcoholic Steatohepatitis (NASH) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Galmed Pharmaceuticals 2017 Nonalcoholic Steatohepatitis (NASH) Business Region Distribution Analysis
8.11 GENFIT SA
8.12 Gilead Science
8.13 Novo Nordisk
8.14 Immuron
8.15 Intercepts Pharmaceuticals
8.16 Enzo Biochem
8.17 Tobira Therapeutics

9 DEVELOPMENT TREND OF ANALYSIS OF NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET

9.1 Global Nonalcoholic Steatohepatitis (NASH) Market Trend Analysis
  9.1.1 Global 2018-2025 Nonalcoholic Steatohepatitis (NASH) Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Nonalcoholic Steatohepatitis (NASH) Sales Price Forecast
9.2 Nonalcoholic Steatohepatitis (NASH) Regional Market Trend
  9.2.1 North America 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Forecast
  9.2.2 China 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Forecast
  9.2.3 Europe 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Forecast
  9.2.5 Japan 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Forecast
  9.2.6 India 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Forecast
9.3 Nonalcoholic Steatohepatitis (NASH) Market Trend (Product Type)
9.4 Nonalcoholic Steatohepatitis (NASH) Market Trend (Application)

10 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKETING TYPE ANALYSIS

10.1 Nonalcoholic Steatohepatitis (NASH) Regional Marketing Type Analysis
10.2 Nonalcoholic Steatohepatitis (NASH) International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Nonalcoholic Steatohepatitis (NASH) by Region
10.4 Nonalcoholic Steatohepatitis (NASH) Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NONALCOHOLIC STEATOHEPATITIS (NASH)

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Nonalcoholic Steatohepatitis (NASH)
Table Product Specifications of Nonalcoholic Steatohepatitis (NASH)
Table Classification of Nonalcoholic Steatohepatitis (NASH)
Figure Global Production Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2017
Figure Weight Loss Treatment Picture
Table Major Manufacturers of Weight Loss Treatment
Figure Insulin-Sensitizing Agents Picture
Table Major Manufacturers of Insulin-Sensitizing Agents
Figure Lipid-Lowering Drugs Picture
Table Major Manufacturers of Lipid-Lowering Drugs
Figure Antioxidants Picture
Table Major Manufacturers of Antioxidants
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Nonalcoholic Steatohepatitis (NASH)
Figure Global Consumption Volume Market Share of Nonalcoholic Steatohepatitis (NASH) by Application in 2017
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Research Institute Examples
Table Major Consumers in Research Institute
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Nonalcoholic Steatohepatitis (NASH) by Regions
Figure North America Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) (2013-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) (2013-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) (2013-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) (2013-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) (2013-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) (2013-2025)
Table Nonalcoholic Steatohepatitis (NASH) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nonalcoholic Steatohepatitis (NASH) in 2017
Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
Figure Industry Chain Structure of Nonalcoholic Steatohepatitis (NASH)
Table Capacity and Commercial Production Date of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure Global 2013-2018E Nonalcoholic Steatohepatitis (NASH) Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Nonalcoholic Steatohepatitis (NASH) Market Size (Value) and Growth Rate
Table 2013-2018E Global Nonalcoholic Steatohepatitis (NASH) Capacity and Growth Rate
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Capacity (K Pcs) List (Company Segment)
Table 2013-2018E Global Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) List (Company Segment)
Table 2013-2018E Global Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure North America 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Figure North America 2017 Nonalcoholic Steatohepatitis (NASH) Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure China 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Figure China 2017 Nonalcoholic Steatohepatitis (NASH) Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure Europe 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Figure Europe 2017 Nonalcoholic Steatohepatitis (NASH) Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure Southeast Asia 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Figure Southeast Asia 2017 Nonalcoholic Steatohepatitis (NASH) Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure Japan 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Figure Japan 2017 Nonalcoholic Steatohepatitis (NASH) Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Nonalcoholic Steatohepatitis (NASH) 2013-2018E
Figure India 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs)
Figure India 2017 Nonalcoholic Steatohepatitis (NASH) Sales Market Share
Table Global 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Type
Table Different Types Nonalcoholic Steatohepatitis (NASH) Product Interview Price
Table Global 2013-2018E Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Application
Table Different Application Nonalcoholic Steatohepatitis (NASH) Product Interview Price
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2017 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Cerenis Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2017 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Connexios Life Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2015 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Genfit Information List
Table Product A Overview
Table Product B Overview
Table 2017 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Genfit Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Islet Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2017 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Nimbus Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2017 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Verva Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Viking Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2017 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Astazeneca Plc Information List
Table Product A Overview
Table Product B Overview
Table 2017 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table Galmed Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Business Region Distribution
Table GENFIT SA Information List
Table Gilead Science Information List
Table Novo Nordisk Information List
Table Immuron Information List
Table Intercepts Pharmaceuticals Information List
Table Enzo Biochem Information List
Table Tobira Therapeutics Information List
Figure Global 2018-2025 Nonalcoholic Steatohepatitis (NASH) Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 Nonalcoholic Steatohepatitis (NASH) Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Nonalcoholic Steatohepatitis (NASH) by Type 2018-2025
Table Global Consumption Volume (K Pcs) of Nonalcoholic Steatohepatitis (NASH) by Application 2018-2025
Table Traders or Distributors with Contact Information of Nonalcoholic Steatohepatitis (NASH) by Region

More Publications

Need Help?

Ask a Question

Market Reports

All Categories